Inhalational drug delivery in pulmonary aspergillosis

Pharmacology, Toxicology and Pharmaceutical Science

• Lung Aspergillosis 100%
• Antifungal Agent 100%
• Diseases 66%
• Infection 66%
• Lung Infection 66%
• Human 33%
• Chronic Obstructive Lung Disease 33%
• Mycosis 33%
• Nebulizer 33%
• Aspergillosis 33%
• Cystic Fibrosis 33%
• Asthma 33%
• Metered-Dose Inhaler 33%
• Dry Powder Inhaler 33%
• Immunocompromised Patient 33%

Keyphrases

• Inhalation Therapy 33%
• Aspergillosis 33%
• Therapeutic Failure 33%
• Inhalation Drug Delivery 33%
• Bench to Bedside 33%